Show Summary Details
Page of

Medication Treatment Strategies for Psychosis 

Medication Treatment Strategies for Psychosis
Medication Treatment Strategies for Psychosis

Philip G. Janicak

and Kumail Hussain

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 January 2022

Schizophrenia is a serious mental disorder that afflicts about 1 percent of the world population. It usually begins in adolescence, often evolving into a chronic, recurrent, and disabling condition. Efforts to better identify and treat individuals at high risk or early in the course of the illness presently offer the best opportunity to positively alter the long-term prognosis. Antipsychotic agents play a key role in stabilizing patients at several stages in the illness process, allowing them to more effectively participate in various psychoeducational, psychosocial, and psychotherapeutic efforts. Many patients, however, do not adequately benefit from existing agents or cannot tolerate their related complications. Thus, there are a variety of ongoing initiatives to develop alternative treatments that will further improve efficacy, safety, and tolerability. This chapter reviews these issues, focusing on practical ways to improve treatment delivery with the ultimate goal of helping patients achieve recovery.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.